Endpoints News Apr 8, 2026 Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Endpoints News Apr 7, 2026 Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data
Endpoints News Mar 25, 2026 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News Mar 24, 2026 Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Endpoints News Dec 18, 2025 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Endpoints News Dec 5, 2025 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme